The Early Warning System for the Diabetic Encephalopathy
Recruiting · NCT02420470 · Observational (researchers observe without assigning treatment) · Lead sponsor: Tang-Du Hospital
View the official record on ClinicalTrials.gov →What this trial is about
Diabetes( mainly type II diabetes )lead to the central nervous system (CNS) function impairment, especially the mild cognitive impairment that increased the risk of progression to dementia.The primary objectives are defined according to a hierarchical design: i) to tailor and apply multi-parametric, functional MRI techniques to identify cerebral abnormalities (cerebral biomarkers) in type 2 diabetes mellitus and prodromal diabetes mellitus ; ii) to assess whether these cerebral biomarkers are associated with cognitive decrements;iii) to follow up with the putative prediabetic condition patients to verify whether they can transform into diabetes.
Who can take part
Inclusion criteria
- without dementia
- Inform Consent Form
- Education time more than 6 years
- blood glucose matches the group standard
Exclusion criteria
- Pregnant woman
- suffer from serious brain disease
- Magnetic resonance contraindications
- lack of compliance
- image quality is too poor to deal with
Where it is running
1 location listed.
- Tangdu Hospital - Xi'an, Shaanxi, China